Navigation Links
Hologic Announces Third Quarter Fiscal 2011 Operating Results
Date:8/1/2011

r 10.9%, related to the contribution from sales of our MyoSure hysteroscopic tissue removal system (MyoSure) from our acquisition of Interlace Medical, Inc. (Interlace) in January 2011 and growth in sales of both our NovaSure endometrial ablation (NovaSure) and Adiana permanent contraception (Adiana) systems; and (iv) an increase in Skeletal Health revenues of $0.7 million, or 3.2%, primarily due to an increase in bone densitometry sales of approximately 19% over the third quarter of fiscal 2010.

For the third quarter of fiscal 2011, Hologic reported net income of $36.2 million, or $0.14 per diluted share, compared with net income of $27.4 million, or $0.10 per diluted share, in the third quarter of fiscal 2010.

The Company's non-GAAP adjusted net income increased 9.4% to $85.5 million, or $0.32 per diluted share, in the third quarter of fiscal 2011 compared to $78.2 million, or $0.30 per diluted share, for the same period in the prior year. The Company's fiscal 2011 and 2010 third quarter non-GAAP adjusted net income primarily excludes: (i) a charge of $59.7 million and $57.1 million, respectively, attributable to the amortization of intangible assets; (ii) a non-cash interest expense charge of $18.2 million and $18.5 million, respectively, related to the Company's Convertible Notes; and (iii) $1.7 million and $0.8 million, respectively, of acquisition-related costs and charges. The Company's fiscal 2011 third quarter non-GAAP adjusted net income also excludes $2.7 million of charges to operating expenses attributable to contingent consideration relating to the Sentinelle Medical, Inc. (Sentinelle), Interlace, and TCT International Co. Ltd. (TCT) acquisitions.

For the nine months ended June 25, 2011, revenues totaled $1.32 billion, an increase of 5.7% compared to revenues of $1.25 billion in the nine months ended June 26, 2010. This increase resulted from growth in revenues in all four of our operating segments, primarily from: (i) grow
'/>"/>

SOURCE Hologic, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Related medicine technology :

1. Three Year Analysis of Treatment Efficacy, Cosmesis, and Toxicity Support use of the Hologic Mammosite Radiation Therapy System
2. ALS Therapy Development Institute Partners with Clinical Centers to Establish Pathological Mechanisms of Lou Gehrigs Disease
3. Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials
4. Paclitaxel Poliglumex (OPAXIO(TM)) Added to Cisplatin and Radiation Produces 45% Pathologic Complete Remissions in Patients With Esophageal Cancer
5. Clinical and Histopathological Results Using Pollogens TriPollar(TM) Radio Frequency Technology Published in the June Issue of the Journal of Cosmetic and Laser Therapy
6. Hologic Receives CE Marking for the ThinPrep(R) Integrated Imager
7. OPAXIO Produces High Rates of Pathologic Complete Remission in Patients with Advanced Esophageal Cancer; Study Paves Way for Potential Registration Trial as Radiation Sensitizer
8. Hologic Expands Healthcare Investment in Asia
9. Hologic to Host Investor Reception at RSNA 2009
10. Hologic to Present at Citis 2009 Sixth Annual Small/Mid Cap Conference
11. Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... 23, 2014 The Board of Directors of ... provider of clinical trial imaging solutions, announced today that ... president and chief executive officer, effective immediately.  Mr. Converse ... and has held the positions of interim president and ... Dr. Charles E. Phelps , Ph.D., chairman of ...
(Date:7/23/2014)... 23, 2014 NOT FOR RELEASE, ... INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO ... REGULATIONS OF SUCH JURISDICTION. AbbVie (NYSE: ... Friday, July 25, 2014, before the market opens. ... call at 8 a.m. Central time (9 a.m. Eastern). It ...
(Date:7/23/2014)... 23, 2014 /PRNewswire-iReach/ -- Use of Risk Evaluation and ... delay generic market entry results in $5.4 billion in ... and analysis by economic consulting firm Matrix ... http://photos.prnewswire.com/prnh/20140723/129680 Required by the Food and ... REMS programs are intended to improve drug safety by ...
Breaking Medicine Technology:Eric T. Converse Named President And Chief Executive Officer Of VirtualScopics, Inc. 2Eric T. Converse Named President And Chief Executive Officer Of VirtualScopics, Inc. 3Eric T. Converse Named President And Chief Executive Officer Of VirtualScopics, Inc. 4AbbVie to Host Second-Quarter Earnings Conference Call 2AbbVie to Host Second-Quarter Earnings Conference Call 3AbbVie to Host Second-Quarter Earnings Conference Call 4AbbVie to Host Second-Quarter Earnings Conference Call 5AbbVie to Host Second-Quarter Earnings Conference Call 6New Analysis Finds $5.4 Billion In Annual Lost Savings From Strategies Geared Toward Delaying Generic Drug Entry 2
... Reactions to House Dust Mite in... -- OXFORD, England, November 18, 2010 ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... BitlyCB.alertResponse = function(data) { var s = ,; var first_result; // Results are keyed by longUrl, so we need ...
... Update for the Third Quarter 2010 -- AMSTERDAM, November 18, 2010 ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... = function(data) { var s = ,; var first_result; // Results are keyed by longUrl, so we need to ...
Cached Medicine Technology:Circassia Achieves Major Reduction in Allergic Reactions to House Dust Mite in Phase II Clinical Study of Novel T-cell Vaccine 2Circassia Achieves Major Reduction in Allergic Reactions to House Dust Mite in Phase II Clinical Study of Novel T-cell Vaccine 3Circassia Achieves Major Reduction in Allergic Reactions to House Dust Mite in Phase II Clinical Study of Novel T-cell Vaccine 4Circassia Achieves Major Reduction in Allergic Reactions to House Dust Mite in Phase II Clinical Study of Novel T-cell Vaccine 5Circassia Achieves Major Reduction in Allergic Reactions to House Dust Mite in Phase II Clinical Study of Novel T-cell Vaccine 6Circassia Achieves Major Reduction in Allergic Reactions to House Dust Mite in Phase II Clinical Study of Novel T-cell Vaccine 7Circassia Achieves Major Reduction in Allergic Reactions to House Dust Mite in Phase II Clinical Study of Novel T-cell Vaccine 8AMT Provides Business Update for the Third Quarter 2010 2AMT Provides Business Update for the Third Quarter 2010 3AMT Provides Business Update for the Third Quarter 2010 4AMT Provides Business Update for the Third Quarter 2010 5AMT Provides Business Update for the Third Quarter 2010 6AMT Provides Business Update for the Third Quarter 2010 7AMT Provides Business Update for the Third Quarter 2010 8
(Date:7/23/2014)... Celebrating a decade of philanthropy in 2014, ... awarding of $1,070,000 in grants to 20 New Jersey ... the Foundation’s 1,000th grant. , “The Horizon Foundation for ... supporting community-based organizations that are working to improve public ... Garden State,” said Robert A. Marino, Horizon Blue Cross ...
(Date:7/23/2014)... growing body of research suggesting a safe and ... postmenopausal breast cancer, with fewer detrimental side effects ... therapies. The study will be published in final ... Biology and Endocrinology . , Breast cancer is ... the United States. Approximately 70% of breast cancers ...
(Date:7/23/2014)... 23, 2014 Global Cardio Care, Inc., ... External Counterpulsation (EECP), is celebrating the 100th birthday ... at the health center. , Weber has been ... receiving ongoing EECP therapy since 1999, he no longer ... CEO of Global Cardio Care, introduced the Sara ...
(Date:7/23/2014)... Memphis, Tenn. (PRWEB) July 23, 2014 The voice ... the telephone call that brought the news he was infected with ... stopped for a little bit and next thing you know I ... a baby.” , Yet the message was hopeful when the recording ... the end of you . . . because it is ...
(Date:7/23/2014)... News) -- For patients infected with both HIV and ... both viruses, a small study suggests. Researchers said ... for people with the two diseases. "The ... an important role in the management of individuals with ... Kenneth Sherman, a professor of medicine at the University ...
Breaking Medicine News(10 mins):Health News:The Horizon Foundation for New Jersey Awards More than $1 million in Grants to 20 Non-profit Organizations 2Health News:The Horizon Foundation for New Jersey Awards More than $1 million in Grants to 20 Non-profit Organizations 3Health News:The Horizon Foundation for New Jersey Awards More than $1 million in Grants to 20 Non-profit Organizations 4Health News:The Horizon Foundation for New Jersey Awards More than $1 million in Grants to 20 Non-profit Organizations 5Health News:Hormones after breast cancer: Not fuel for the fire after all? 2Health News:Hormones after breast cancer: Not fuel for the fire after all? 3Health News:Hormones after breast cancer: Not fuel for the fire after all? 4Health News:Hormones after breast cancer: Not fuel for the fire after all? 5Health News:Global Cardio Care Celebrates EECP Patient’s 100th Birthday 2Health News:HIV clinic-based audio project emphasizes the power of patient voices 2Health News:HIV clinic-based audio project emphasizes the power of patient voices 3Health News:HIV Meds May Also Help Control Hepatitis C, Study Finds 2
... and reliable information are essential for women who find ... live in rural areas where health services are patchy ... in the latest issue of the Journal of Advanced ... provider in Nova Scotia, a predominantly rural Canadian province ...
... rarely detected before it has grown large enough to impair ... disease to fight, especially since chemotherapy is not very effective. ... Faingold may open the door for very promising new treatment ... the cover of the February 2008 issue of Clinical Cancer ...
... Feb. 19 Viola Startzman, M.D. of,Wooster, Ohio is ... Award for,Excellence in Volunteerism. Presented by the American Medical ... physicians for,commitment to volunteer medical care to those without ... presents the award in association with the,Pfizer Medical Humanities ...
... CHICAGO, Feb. 19 The American Medical,Association ... the highest ideals of medical service in ... physicians will be honored during the,sixth annual ... 31, 2008,preceding the American Medical Association,s National ...
... LONDON, February 19 NHS Choices ( http://www.nhs.uk ... a new interactive tool aimed,to help people assess ... limits for sensible drinking., Based on NHS ... enables users,to find out in seconds whether they ...
... Delivered to German Government in January, BETHESDA, ... of global health economics has just delivered to ... of drug policy produced in,Europe in more than ... The 70-page report, commissioned last year by ...
Cached Medicine News:Health News:Menopausal women need better health care and community support in rural areas 2Health News:Menopausal women need better health care and community support in rural areas 3Health News:HSP90: New point of view on melanoma of the eye, at the MUHC 2Health News:AMA Foundation Honors Wooster, Ohio Physician for Volunteerism 2Health News:AMA Foundation Honors Compassionate Physicians With Excellence in Medicine Awards 2Health News:AMA Foundation Honors Compassionate Physicians With Excellence in Medicine Awards 3Health News:AMA Foundation Honors Compassionate Physicians With Excellence in Medicine Awards 4Health News:AMA Foundation Honors Compassionate Physicians With Excellence in Medicine Awards 5Health News:United BioSource Scientist Leads Development of New Guidelines for Drug Reimbursement by German Government 2
Straight Shafts with Serrated 5mm Platform with 0.2 tips; overall length 105mm In Titanium...
Straight Shafts with 0.12mm 1X2 Teeth With 5mm Tying Platform; In Titanium...
45 Degree Angle With 0.3, 12 Teeth with 5mm Tying Platform; In Titanium....
0.3mm tips; 9.5mm from tips to cross action; in Titanium....
Medicine Products: